Texas Medicaid and GLP-1s
The takeaway
Texas Medicaid added prior authorization for Wegovy's liver-disease use and revised its Zepbound criteria in November 2025.
Reading the state documents
Texas publishes its GLP-1 decisions as short notices rather than criteria documents, and two of them landed on the same day in November 2025. One added prior authorization for Wegovy's liver-disease indication after a review-board vote. The other updated the Zepbound guide, adding two product codes and changing how far back a disqualifying diagnosis counts. The provider manual chapter that governs outpatient drugs mentions none of these drugs.
What changed, and what the document says
A new authorization, with a start date
Conditions applyTexas dates the requirement to the day and names who it applies to, including managed care.
“Beginning November 24, 2025, Texas Medicaid and managed care organizations (MCOs) will require providers to get clinical prior authorization for the Wegovy MASH indication for clients who are enrolled in Medicaid fee-for-service.”
Texas Medicaid & Healthcare Partnership (TMHP) — Last updated on 11/21/2025
It went through the review board
ContextThe criteria were approved by the state's drug utilization review board before publication.
“The Texas Drug Utilization Review (DUR) Board has reviewed and approved the clinical criteria for the Wegovy MASH indication.”
Texas Medicaid & Healthcare Partnership (TMHP) — Last updated on 11/21/2025
The Zepbound guide changed the same day
ContextA second notice, same date, revising the tirzepatide criteria. The typo in the drug's name is the state's own.
“The Vendor Drug Program (VDP) has updated the Zepbound (tirzapetide) clinical criteria guide.”
Texas Medicaid & Healthcare Partnership (TMHP), Vendor Drug Program — Last updated on 11/21/2025
A two-year look-back on two diagnoses
Conditions applyThe change is technical and it matters: how far back a thyroid-cancer or endocrine-neoplasia history disqualifies you.
“changed the look-back period for the following diagnoses to 730 days”
Texas Medicaid & Healthcare Partnership (TMHP), Vendor Drug Program — Last updated on 11/21/2025
Two new product codes
ContextThe higher tirzepatide strengths were added to the table of drugs needing authorization.
“56686 for Zepbound 12.5 mg/0.5 ml vial”
Texas Medicaid & Healthcare Partnership (TMHP), Vendor Drug Program — Last updated on 11/21/2025
Both notices carry the same stamp
ContextThe date on these is a last-updated stamp, not an effective date — the effective dates are stated separately in the text.
“Last updated on 11/21/2025”
Texas Medicaid & Healthcare Partnership (TMHP) — Last updated on 11/21/2025
Telehealth in Texas
- Enhance MDPartnerBMinor gapSee Enhance MD pricing (opens in a new tab)No verified comparable monthly GLP-1 medication price.
Price details
- See the review for plan prices and full terms.
- Sprout HealthPartnerBMinor gapSee Sprout Health pricing (opens in a new tab)No verified comparable monthly GLP-1 medication price.
Price details
- See the review for plan prices and full terms.
- Gala HealthPartnerCCaveatSee Gala Health pricing (opens in a new tab)$1,299a month, medication onlybrand Ozempic (semaglutide), cash priceAdditional fees not verified.
Price details
- No separate monthly fee was found in the pages reviewed. Other charges may apply.
- Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
Which of these companies serve Texas?
Of the 387 companies we grade, 34 publish a list of the states they are licensed in. We checked 251 more and found no such list on any page we read; 102 we have not checked either way.
28 of those lists name Texas: Red Mountain Weight Loss, Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Levity, Green Cap Health, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, TOM Weight Loss, Willow, The Virtual NP, VevaRx, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, Allara Health, MEDvidi, PCOS Sisters, Mixx Health & Wellness, and Hormonally Balanced. That is a licensure claim each company makes about itself, not something we checked with a state board.
A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.
Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.
Sources
Source dates below are the dates printed on the documents.
- Wegovy Clinical Prior Authorization for New Metabolic Dysfunction-Associated Steatohepatitis (MASH) Indication — Texas Medicaid & Healthcare Partnership (TMHP). Last-updated stamp printed under the headline; the notice separately states an implementation date of November 24, 2025: Last updated on 11/21/2025.
- Zepbound Clinical Prior Authorization Criteria Guide Updates — Texas Medicaid & Healthcare Partnership (TMHP), Vendor Drug Program. Last-updated stamp printed under the headline: Last updated on 11/21/2025.
Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.
If you're paying cash instead
These providers list Texas in their service area. Partners appear first. These are medication prices, not confirmed monthly totals. Other fees may apply; check each provider’s terms before choosing.
Some providers pay us a commission when you sign up through our links, at no extra cost to you.
| Provider | Monthly price and terms | Go to the provider |
|---|---|---|
Enhance MDBMinor gap | No verified comparable monthly GLP-1 medication price. See the review for plan prices and full terms. | View pricing at Enhance MD (opens in a new tab)Partner |
Sprout HealthBMinor gap | No verified comparable monthly GLP-1 medication price. See the review for plan prices and full terms. | View pricing at Sprout Health (opens in a new tab)Partner |
Gala HealthCCaveat | $1,299 a month, medication only brand Ozempic (semaglutide), cash price Brand-name Ozempic, quoted as a cash price. Gala says insurance may reduce it and does not publish what it would reduce it to. Additional fees not verified. Price details
| View pricing at Gala Health (opens in a new tab)Partner |
HumeCare+CCaveat | $249Signup price a month, medication only compounded semaglutide, six-month plan $179 the first month, $249 a month after; the checkout totals the six months at $1,424. The card shows the later price only once the plan is selected. Additional fees not verified. Price details
| View pricing at HumeCare+ (opens in a new tab)Partner |
WillowCCaveat | $299 a month, medication only compounded semaglutide injection Printed on the product page with no asterisk and no dose qualifier. The comparison page and the terms both add one. Additional fees not verified. Price details
| View pricing at Willow (opens in a new tab)Partner |
TeleClinicAVerified | $79 a month, medication only compounded semaglutide Billed monthly, same price at every vial strength, and the product page says the rate is locked for the life of the membership. Additional fees not verified. Price details
| View pricing at TeleClinic (opens in a new tab) |
TelePeptideAVerified | $229 a month, medication only compounded semaglutide Dissolvable tablet, month-to-month. TelePeptide states on the same page that it does not sell branded GLP-1s. Additional fees not verified. Price details
| View pricing at TelePeptide (opens in a new tab) |
Care Bare RxBMinor gap | $199 a month, medication only compounded tirzepatide Both compounded drugs are quoted at the same starting figure, on one line that also puts brand names on them. Additional fees not verified. Price details
| View pricing at Care Bare Rx (opens in a new tab) |
Our grading method and how we verify a price explain what those letters mean and where these figures came from.